The Global Needle-free Injection System Market size is set to grow by USD 272 billion by 2026 according to MarketsandMarkets. Growth in this market is mainly driven by technological advancements, increasing demand for self-injection devices, and the rising incidence of chronic diseases.

Technological advancements in lab freezers also drive the growth of this market. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments. The global Needle-free Injection System market is fragmented, and the degree of fragmentation will accelerate during the forecast period. 

Request Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861

Needle-free Injection System Market Segmentation

Global Needle-free Injection System Market, by Application

• Vaccine delivery
• Insulin delivery
• Oncology
• Pain management
• Dermatology
• Other applications

Geography

• North America
• Europe
• Asia
• ROW

Global Needle-free Injection System Market Vendor Analysis

To help businesses improve their market position, MnM report provides a detailed analysis of around 25 vendors operating in the market. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861

Some of the major vendors of the global Needle-free Injection System market in the health care industry include:

PharmaJet (US), Portal Instruments (US), Medical International Technology, Inc (MIT) (US), NuGen Medical Devices (Canada), Crossject SA (US), and Bioject Medical Technologies (US).

Regional Analysis

North America accounted for the largest share of 58% of the needle-free injection market, followed by Europe, the Asia Pacific (APAC), Latin America, and the Middle East Africa. However, the APAC region is expected to grow at the highest CAGR of 18.7% during the forecast period. The rapidly developing healthcare industry in China and India, growth in the aging population, rising life expectancy, rising per capita income, increasing investments in the region by key market players, the expansion of private-sector hospitals clinics to rural areas, the availability of low-cost labor for manufacturing, the presence of a favorable regulatory environment, and growing demand for self-injectable devices testing are supporting market growth in the APAC region.

Global Needle-free Injection System Market Key Highlights

• CAGR of the market during the forecast period
• Detailed information on factors that will assist global Needle-free Injection System market growth during the next five years
• Estimation of the global Needle-free Injection System market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the global Needle-free Injection System market
• Analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of global Needle-free Injection System market vendors

Key Developments in Global Needle-free Injection System Market

• In December 2021, PharmaJet partner, Nykode Therapeutics announces phase 1/2 clinical trial with next-generation DNA-based COVID-19 vaccine candidates
• In August 2021, PharmaJet partner Zydus Cadila announced Emergency Use Authorization approval for world’s first plasmid DNA COVID-19 vaccine deliver via needle-free injection.
• In May 2021, Enesi pharma achieves key milestone in development of thermostable solid-dose live vaccines against Measles and Rubella and soon entering into clinical trials

Each of these players has been profiled in the global Needle-free Injection System market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

To speak to our analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=165815861

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: [email protected]

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/needle-free-injection-system-market.asp

Visit Our Web Site: https://www.marketsandmarkets.com

Content Source: https://www.marketsandmarkets.com/PressReleases/needle-free-injection-system.asp